近期一項研究證實：一種新型檢測方法能夠在免疫系統嚴重受到抑制的HIV患者中檢測結核。

Oxford Immunotec(Abingdon, UK)宣布了這項研究，這項研究在Chelsea和Westminster醫院(London, UK)中進行的，顯示該公司T-Spot結核檢測能夠在HIV患者中檢測TB，即使在他們的CD4 T細胞計數小于200/µl的時候。該研究還證實了T-Spot結核檢測能夠作為HIV患者結核德排除檢測。這些結果在2006年3月Brighton (UK)英國HIV學會年度會議上進行了報道。

Test Detects TB in HIV Patients
 
A recent study has confirmed that a new test is able to detect tuberculosis (TB) in HIV patients whose immune systems are severely compromised.

Oxford Immunotec (Abingdon, UK) announced that the study, which was performed at the Chelsea and Westminster hospital (London, UK), showed that the company’s T-Spot.TB test is able to detect TB in HIV patients, even when their CD4 T cell count is less than 200 cells/µl. The study also confirmed the ability of the T-Spot.TB to be used as a “rule-out” test for TB in HIV patients. The results of the study were presented at the annual meeting of the British HIV Association in Brighton (UK) in March 2006.